Log in to save to my catalogue

Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenoc...

Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenoc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2430092857

Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma

About this item

Full title

Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

Journal of cancer research and clinical oncology, 2020-11, Vol.146 (11), p.2851-2859

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Purpose
TP53/EGFR co-mutation has been reported to affect the efficacy of epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) in lung adenocarcinoma (LUAD). However, its impact on survival is unclear. In this analysis, we explored the prognostic effect of TP53/EGFR co-mutation in LUAD.
Methods
Clinical data and transc...

Alternative Titles

Full title

Prognostic value of TP53 co-mutation status combined with EGFR mutation in patients with lung adenocarcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2430092857

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2430092857

Other Identifiers

ISSN

0171-5216

E-ISSN

1432-1335

DOI

10.1007/s00432-020-03340-5

How to access this item